News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
619,650 Results
Type
Article (51149)
Company Profile (414)
Press Release (568087)
Section
Business (165438)
Career Advice (3062)
Deals (30188)
Drug Delivery (92)
Drug Development (79559)
Employer Resources (174)
FDA (15113)
Job Trends (13275)
News (296189)
Policy (28996)
Tag
Academia (2817)
Alliances (44215)
Alzheimer's disease (1273)
Approvals (15011)
Artificial intelligence (124)
Bankruptcy (283)
Best Places to Work (10823)
Biotechnology (319)
Breast cancer (108)
Cancer (941)
Cardiovascular disease (80)
Career advice (2579)
Cell therapy (226)
Clinical research (62506)
Collaboration (336)
Compensation (160)
COVID-19 (2566)
Cystic fibrosis (83)
Data (861)
Diabetes (138)
Diagnostics (5462)
Drug pricing (82)
Earnings (59564)
Employer resources (153)
Events (103250)
Executive appointments (234)
FDA (15546)
Funding (303)
Gene therapy (170)
GLP-1 (590)
Government (4328)
Healthcare (18219)
Infectious disease (2629)
Inflammatory bowel disease (111)
Interviews (594)
IPO (14408)
Job creations (2776)
Job search strategy (2126)
Layoffs (383)
Legal (6011)
Lung cancer (160)
Manufacturing (159)
Medical device (11651)
Medtech (11654)
Mergers & acquisitions (15841)
Metabolic disorders (380)
Neuroscience (1526)
NextGen Class of 2024 (6336)
Non-profit (4472)
Northern California (1160)
Obesity (222)
Opinion (231)
Patents (94)
People (48238)
Phase I (19601)
Phase II (27677)
Phase III (20577)
Pipeline (206)
Postmarket research (2349)
Preclinical (8421)
Radiopharmaceuticals (253)
Rare diseases (201)
Real estate (5090)
Regulatory (19877)
Research institute (2509)
Resumes & cover letters (495)
Southern California (1039)
Startups (3301)
United States (11290)
Vaccines (536)
Weight loss (178)
Date
Today (84)
Last 7 days (704)
Last 30 days (2695)
Last 365 days (35328)
2024 (29952)
2023 (39157)
2022 (49452)
2021 (53753)
2020 (51562)
2019 (44518)
2018 (33668)
2017 (31119)
2016 (30661)
2015 (35302)
2014 (27523)
2013 (22630)
2012 (23872)
2011 (24318)
2010 (22149)
Location
Africa (871)
Arizona (130)
Asia (36751)
Australia (6569)
California (2633)
Canada (1113)
China (211)
Colorado (116)
Connecticut (121)
Europe (84881)
Florida (371)
Georgia (95)
Illinois (313)
Indiana (156)
Kansas (93)
Maryland (480)
Massachusetts (2241)
Michigan (138)
Minnesota (227)
New Jersey (788)
New York (807)
North Carolina (689)
Northern California (1160)
Ohio (121)
Pennsylvania (716)
South America (1156)
Southern California (1039)
Texas (367)
Washington State (325)
619,650 Results for "the forsyth institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Flightpath Biosciences and the Forsyth Institute Enter Into Co-Development Agreement Targeting Oral Disease
Flightpath Biosciences, Inc. announced today that it has signed a landmark development agreement with the Forsyth Institute, a globally recognized leader in the fields of oral health research and clinical care.
October 3, 2023
·
4 min read
Pharm Country
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics
Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.
May 17, 2024
·
3 min read
Business
Coya Therapeutics Expands Sponsored Research Collaboration with Houston Methodist Research Institute
Coya Therapeutics, Inc. announces the expansion of its research collaboration with the Houston Methodist Research Institute (“HMRI”) through a sponsored research agreement (SRA) covering multiple initiatives.
June 20, 2024
·
10 min read
Esri Technology Used By ALS Therapy Development Institute to Map Clinical Trials
The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech dedicated to ending amyotrophic lateral sclerosis (ALS), has used mapping technology from Esri, the global leader in location intelligence, to develop the ALS Trial Navigator.
June 21, 2024
·
4 min read
Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics
Providence Therapeutic Holdings Inc. and the Ontario Institute for Cancer Research, Ontario’s largest publicly funded cancer research institute delivering real-world solutions to people affected by cancer, announced the signing of a collaboration agreement for mRNA drug discovery and development.
May 23, 2024
·
3 min read
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
Senti Biosciences, Inc., a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, announced that the California Institute for Regenerative Medicines has awarded an $8 million grant to Senti Bio.
July 1, 2024
·
9 min read
Biotech Bay
Kyverna Therapeutics and National Institutes of Health Co-Author Seminal Review on Cell Therapy for Autoimmunity in Nature Reviews Immunology
Kyverna Therapeutics, Inc. announced the publication in Nature Reviews Immunology of a manuscript co-authored with the National Institutes of Health titled “Chimeric antigen receptor T cell therapy for autoimmune disease”.
June 10, 2024
·
5 min read
Business
Oblique Therapeutics and the KTH Royal Institute of Technology (KTH) have entered into a strategic collaboration to analyse protein structures using supercomputers
Oblique Therapeutics, a leading biotechnology company specialising in the development of new drug candidates, is pleased to announce today that they have entered into an agreement with the KTH Royal Institute of Technology to utilise KTH’s state-of-the-art supercomputer resources for analysing protein structures.
June 18, 2024
·
3 min read
Business
Georgia Bio Names South Forsyth High School Junior as 2022 Georgia BioGENEius Winner
Georgia Bio and the BioEd Institute named Mokshith Mannuru, a junior at South Forsyth High School in Cumming, GA, as the winner of the 2022 Georgia BioGENEius Challenge.
April 13, 2022
·
4 min read
Business
Qurient Therapeutics Enters CRADA with the National Cancer Institute to Collaborate on a Phase 1/2 Clinical Study of Q901 in Combination with TROP2-ADC
Qurient Therapeutics Enters CRADA with the National Cancer Institute to Collaborate on a Phase 1/2 Clinical Study of Q901 in Combination with TROP2-ADC.
May 21, 2024
·
2 min read
1 of 61,965
Next